Published on
In the replay of session two of our “Understanding New Options for CLL” town meeting, a panel of experts discusses strategies for managing life with CLL. Learn more about coping with disease symptoms, treatment side effects and emotional aspects of CLL. In the final chapter of the program, an audience of CLL patients and their loved ones poses their questions to the panel in a Q&A session.
Provided by CLL Global Research Foundation, which received support from AbbVie Inc., Genentech Inc., Gilead Sciences, Pharmacyclics, Inc., Teva Pharmaceuticals and TG Therapeutics. In partnership with The University of Texas MD Anderson Cancer Center.
View more programs featuring Michael Keating, MB, BS , Nicole Lamanna, MD , Wenli Liu, MD , Jeff Folloder and Andrew Schorr
Produced in association with CLL Global Research Foundation and The University of Texas MD Anderson Cancer Center
Become a member to access our latest content and be the first to know about new programs and information.
What CLL research advances are in the pipeline, and will they be available to everyone soon? Dr. Michael Keating explains.
Published:
Why should patients be interested in second-generation CLL inhibitors? Drs. Lamanna and Thompson explain.
Published:
Could checkpoint inhibitors be used to treat CLL? CLL expert, Dr. Nicole Lamanna, explains.
Published:
